+1 (347) 583-0215 (Text also) info@curtiscoulter.com

Oral Peptide Therapeutics – Technologies have been honed to overcome many of the challenges of administering peptide therapeutics orally, but obstacles remain before drug developers can fully realize the vast potential.

Numerous technologies are currently in development that are designed to enable the oral delivery of peptides. Though each has its unique set of properties and capabilities, all must overcome key obstacles to successfully deliver peptides via the oral route.

This week’s available download is titled “Novel Approaches for Enhancing the Oral Bioavailability & Absorption of Peptides” from Rebecca Nofsinger at Merck. This presentation discusses peptide advantages and challenges, permeation enhancers and models to evaluate permeation limitations in oral absorption.

Scroll through the presentation below….

2023 Global Drug Bioavailability Enhancement Summit

(May 16-17, 2023, Princeton, NJ)


Interested to improve the performance of your drug products? Learn 2 years of new drug product development approaches at the 2023 Summit this coming May both in-person & virtual.

Join 160+ leading drug delivery, formulation and development experts and hear 30+ expert sessions. Gain over 2 years worth of new drug product development strategies, formulation approaches, delivery technologies and regulatory updates while decreasing drug product time-to-market in just 2 short days (all available on-demand)!

Save up-to 50% on attendance before Friday 28th October, 2022. Likewise, have a platform technology you would like to explore showcasing to the wider audience this May? Reach out below to find out remaining opportunities.

2021 On-Demand Summits Available for Purchase

(Limited time - Only $299)

Pin It on Pinterest

Share This

Share this with a friend or colleague!